Primary Care Diabetes and Obesity Society

04/09/2026

It's not too late to register for our 22nd National Conference happening on the 18th and 19th November 2026 at the NCC, Birmingham.

Find out more and register now at https://eu1.hubs.ly/H0y4VV00

Sadly, Sunny — PCDOS Cuddle Manager — won’t be making an appearance this year, but he’ll be there in spirit, spreading the pawsitivity!🐶

This conference was developed by the PCDO Society in conjunction with OmniaMed Communications. The sponsoring pharmaceutical, device, training and educational companies have contributed financial support towards this event but have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible. A full list of confirmed sponsors for this event can be found on the website by clicking on the sponsors tab.

03/09/2026

Incretin therapies: Avoiding the pitfalls
Join Heather Bell and Jane Diggle for a practical masterclass exploring the real-world dilemmas we face in primary care regarding incretin therapies, drawing on their own personal experience and the tricky scenarios that usually land on our desks on a Friday afternoon!

A must-attend masterclass for anyone navigating the increasingly complex world of diabetes and obesity in primary care.

02/09/2026

Smart Roadshow comes to London in just 1 week! The day is fast approaching and we're excited for a day of innovation, insight and conversation with clinical experts and peers.

Find out more and register now at https://eu1.hubs.ly/H0xrQ0V0

27/08/2026

Another therapy on the horizon? Pam Brown reviews the REIMAGINE series of trials.

Read it here: https://eu1.hubs.ly/H0xGZc70

27/08/2026

In the latest in our Diabetes Distilled series, Pam Brown summarises the REIMAGINE series of clinical trials which studied Cagrilintide, a long-acting amylin agonist combined with semaglutide as a once weekly subcutaneous injection for people with type 2 diabetes.

Amylin is a neuroendocrine peptide hormone secreted alongside insulin that improves insulin sensitivity, reduces post-prandial glucagon secretion and

26/08/2026

Smart Roadshow is arriving in London in just 2 weeks! We're counting down to a day of innovation, insight and conversations with clinical experts and peers.

Find out more and register now at https://eu1.hubs.ly/H0xrN5r0

24/08/2026

Women with an obese weight trajectory in childhood were 22% less likely to give birth in their late-20s and 44% less likely in their early-30s in this retrospective cohort study. Pam Brown reviews:

https://eu1.hubs.ly/H0xxbhf0

24/08/2026

Hear Nicola Milne explain why our National Conference in Birmingham is a must-attend this November, and particularly the masterclass she will be chairing on neurodiversity, diabetes and obesity.

In this masterclass, Rose Stewart will cover:
• Rethinking care beyond one size fits all
• Challenges with obesity and diabetes management
• Adjustments to improve engagement and adherence

Like what you see? Register now!
https://eu1.hubs.ly/H0xGzFp0

---
This conference was developed by the PCDO Society in conjunction with OmniaMed Communications. The sponsoring pharmaceutical, device, training and educational companies have contributed financial support towards this event but have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible. A full list of confirmed sponsors for this event can be found on the website by clicking on the sponsors tab.

21/08/2026

More take-home points from the PCDO London Conference:

https://eu1.hubs.ly/H0xwMy30

20/08/2026

In an ever-changing landscape, this article has been updated to reflect changes in continuous glucose monitoring sensors and DVLA driving recommendations.

Keep abreast of the changes:
https://eu1.hubs.ly/H0xGZl60